Searched over 200M research papers
10 papers analyzed
These studies suggest cancer is a complex, multistep genetic disease characterized by uncontrolled cell proliferation, with various treatment methods and ongoing research to improve detection, diagnosis, and outcomes.
20 papers analyzed
In 2023, the American Cancer Society projected approximately 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. Notably, prostate cancer incidence increased by 3% annually from 2014 to 2019, reversing a two-decade decline. Conversely, lung cancer incidence in women decreased at half the rate of men, and breast and uterine corpus cancers continued to rise. However, cervical cancer incidence dropped by 65% among women in their early 20s, likely due to the human papillomavirus vaccine. Despite the COVID-19 pandemic, cancer mortality rates continued to decline, with a 33% overall reduction since 1991, largely due to advances in treatment.
Globally, in 2020, there were an estimated 19.3 million new cancer cases and nearly 10 million cancer deaths. The most commonly diagnosed cancers were breast, lung, and prostate, while the leading causes of cancer death were lung, liver, and stomach cancers.
Traditional definitions of cancer describe it as a disease characterized by uncontrolled cell growth and spread. However, modern definitions emphasize the transformed nature of cancer cells and their evolution through natural selection. This perspective highlights the genetic and epigenetic changes that drive cancer progression and metastasis.
The hallmarks of cancer, as outlined by Hanahan and Weinberg, include self-sufficiency in growth signals, insensitivity to antigrowth signals, evasion of apoptosis, limitless replicative potential, induction of angiogenesis, and the ability to invade and metastasize. These principles provide a comprehensive framework for understanding tumor development and resistance to therapy.
Cancer is a genetic disease requiring multiple mutations. Each mutation contributes to cellular multiplication, increasing tumor size, disorganization, and malignancy. Typically, three to six mutations are necessary to complete this process.
Cancer treatment varies by type and stage, including surgery, chemotherapy, radiation therapy, and hormone therapy. Emerging treatments such as immunotherapy, targeted therapies (e.g., tyrosine kinase inhibitors and monoclonal antibodies), and gene therapy are transforming cancer care. Immunotherapy, in particular, has shown promise in treating various cancers, with personalized vaccines representing a significant advancement.
Recent research has highlighted the importance of the physical traits of tumors, such as solid stress, interstitial fluid pressure, stiffness, and altered microarchitecture. These traits contribute to tumor progression, immune evasion, and treatment resistance. Understanding these physical properties can lead to new therapeutic strategies.
Breast cancer is the most common malignancy in women worldwide. It is highly heterogeneous, with molecular features including HER2 activation, hormone receptor activation, and BRCA mutations. Treatment strategies are multidisciplinary, involving surgery, radiation, and systemic therapies tailored to molecular subtypes. Advanced breast cancer with distant metastases remains incurable, but ongoing research aims to individualize therapy and improve outcomes .
Cancer remains a complex and evolving disease, with significant progress in understanding its biology, incidence trends, and treatment options. Advances in molecular biology, immunotherapy, and the understanding of tumor microenvironments are paving the way for more effective and personalized cancer treatments. Continued research and innovation are essential to further reduce cancer mortality and improve patient outcomes.
Most relevant research papers on this topic